I’ve met Saskia at Bayer Global DS&AI F2F meeting
I am Saskia, part of DS&AI - DSG.
Nice to meet you!
I've met Roberta at Bayer DS&AI event
I am a pharmacist from Rio de Janeiro-Brazil and I work as a computational chemist at Bayer since 2021 in the Computational Molecular Design department in Wuppertal. I work side by side with chemists on different projects using our digital tools to design small molecules that maybe one day will help patients! I am passionate about my work and I have the opportunity to also be part of the Steering Group for Transformation and Leadership in the Drug Discovery Science to help transforming the way we work and communicate.
I've met Wolfgang Thielemann at Bayer's DS&AI F2F Madrid
I am heading the Data Assets and Insights Solutions team focusing on creating impact on our pipeline with FAIRified, enriched, semantically integrated data products (e.g., Hubble) in combination with solutions which provide insights to key scientific and business questions along the entire R&D value chain (e.g. Aelixir).
Nico Bernsmeier PhD, Head of Product Owner Modalities and CGT. Trained Molecular Biologist. Joined Bayer 14 years ago. I am passionate about bringing the digital world to the labs. I love the challenge of combining the scientifc aspiration of R&D with the hard reality of IT. Creating a work environement where our product teams can excel in driving their products forward is the challenge we face.
Senior Product Owner Clinical with a long experience in Clinical Processes and Digital Workplace but also interested Enterprise Architecture, Data Science, AI, Enterprise Search and more of the fancy stuff. Privately, I am interested in photography
I met Aaron at the Bayer DS & AI F2F meeting in Madrid
Aaron works at the intersection of science and IT. He has just joined DS & AI as a Product Owner Preclinical, where he will be responsible for introducing digital products that help scientists and advance the R&D strategy within RED Oncology and preMED. He has had multiple roles within IT over his seven years at Bayer, supporting Pharma scientists from research to early development. Prior to joining Bayer he performed doctoral and postdoctoral research in neurobiology, and worked for an R&D-focused software vendor.
